当前位置: X-MOL 学术J. Thorac. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Guidance on the clinical management of E-cigarette or Vaping Associated Lung Injury (EVALI)?
Journal of Thoracic Oncology ( IF 20.4 ) Pub Date : 2020-11-01 , DOI: 10.1016/j.jtho.2020.08.012
Shawn J Rice 1 , Victoria Hyland 1 , Madhusmita Behera 2 , Suresh S Ramalingam 2 , Paul Bunn 3 , Chandra P Belani 1
Affiliation  

In the summer of 2019 there was a rise in clusters of adolescents and young adults in the United States reporting to emergency departments with acute respiratory distress related to e-cigarette or vaping usage. The number of patients with E-cigarette or Vaping Associated Lung Injury (EVALI) continued to rise through the summer before peaking in September 2019. Through the efforts of state and federal public health agencies, officials were able to define the condition, identify the relationship of the respiratory injury to tetrahydrocannabinol (THC)-containing products, and stem the rise in new cases. In this report, we present a comprehensive review of the clinical characteristics and features of EVALI patients and present guidelines for patient care and management to inform and navigate clinicians who may encounter these patients in their clinical practice.

中文翻译:

电子烟或电子烟相关肺损伤 (EVALI) 的临床管理指南?

2019 年夏季,美国越来越多的青少年和年轻人向急诊室报告与使用电子烟或电子烟有关的急性呼吸窘迫。电子烟或电子烟相关肺损伤 (EVALI) 患者的数量在整个夏季持续上升,然后在 2019 年 9 月达到顶峰。通过州和联邦公共卫生机构的努力,官员们能够确定病情,确定两者之间的关系对含四氢大麻酚 (THC) 产品的呼吸系统损伤,并阻止新病例的增加。在这份报告中,
更新日期:2020-11-01
down
wechat
bug